Cargando…

Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial

PURPOSE: Proton therapy (PT) for partial breast irradiation (PBI) in early-stage breast cancer can decrease morbidity versus photon PBI with superior organs-at-risk sparing. We report 3-year outcomes of the first prospective, multicenter, phase II trial of proton PBI. METHODS AND MATERIALS: This Pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, J. Isabelle, Prabhu, Kiran, Hartsell, William F., DeWees, Todd, Sinesi, Christopher, Vargas, Carlos, Benda, Rashmi K., Cahlon, Oren, Chang, Andrew L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450061/ https://www.ncbi.nlm.nih.gov/pubmed/36093343 http://dx.doi.org/10.1016/j.ctro.2022.08.013

Ejemplares similares

Proton Therapy for Partial Breast Irradiation: Rationale and Considerations
por: Choi, J. Isabelle, et al.
Publicado: (2021)

Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003
por: Laughlin, Brady S., et al.
Publicado: (2022)

Comparison of accelerated partial breast irradiation via multicatheter interstitial brachytherapy versus whole breast radiation
por: Ferraro, Daniel J, et al.
Publicado: (2012)

Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial
por: Parzen, Jacob S., et al.
Publicado: (2021)

Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09
por: Mishra, Mark V., et al.
Publicado: (2019)

Quantification of Potential Inequities in Breast Cancer Incidence in New Mexico Through Bayesian Disease Mapping
por: Zahrieh, David, et al.
Publicado: (2021)

Patient-reported outcomes for patients with breast cancer undergoing radiotherapy: A single-center registry experience
por: Laughlin, Brady S., et al.
Publicado: (2022)

Future Perspectives of Proton Therapy in Minimizing the Toxicity of Breast Cancer Radiotherapy
por: Musielak, Marika, et al.
Publicado: (2021)

Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostate cancer
por: Vargas, Carlos E., et al.
Publicado: (2018)

Acute toxicity of intraoperative radiotherapy and external beam-accelerated partial breast irradiation in elderly breast cancer patients
por: Jacobs, D. H. M., et al.
Publicado: (2018)

A method for quantitative evaluations of scanning‐proton dose distributions
por: Allred, Bryce C., et al.
Publicado: (2021)

Patient reported outcomes following proton pencil beam scanning vs. passive scatter/uniform scanning for localized prostate cancer: Secondary analysis of PCG 001-09
por: Mishra, Mark V., et al.
Publicado: (2020)

Application of an automatic segmentation method for evaluating cardiac structure doses received by breast radiotherapy patients
por: Jung, Jae Won, et al.
Publicado: (2021)

A systematic review of clinical outcomes and radiotherapy-associated toxicity in multicatheter accelerated partial breast irradiation
por: Lv, Yang, et al.
Publicado: (2019)

Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group
por: Parzen, Jacob S., et al.
Publicado: (2020)

Accelerated partial-breast irradiation using intensity-modulated proton radiotherapy: do uncertainties outweigh potential benefits?
por: Wang, X, et al.
Publicado: (2013)

Proton therapy for isolated local regional recurrence of breast cancer after mastectomy alone
por: Laughlin, Brady S., et al.
Publicado: (2022)

Patterns of Recurrence Among Higher-Risk Patients Receiving Daily External Beam Accelerated Partial-Breast Irradiation to 40 Gy in 10 Fractions
por: Fitzgerald, Kelly, et al.
Publicado: (2019)

Accuracy and Efficiency of Patient Setup Using Surface Imaging versus Skin Tattoos for Accelerated Partial Breast Irradiation
por: Mueller, Boris, et al.
Publicado: (2023)

Outcome for Children with Metastatic Solid Tumors over the Last Four Decades
por: Perkins, Stephanie M., et al.
Publicado: (2014)

Proton Radiotherapy for Patients With Oligometastatic Breast Cancer Involving the Sternum
por: Johnson, Andrew, et al.
Publicado: (2021)

Pilot/Phase II Trial of Hypofractionated Radiation Therapy to the Whole Breast Alone Before Breast Conserving Surgery
por: Thorpe, Cameron S., et al.
Publicado: (2022)

Accelerated Partial Breast Irradiation with Intensity-Modulated Radiotherapy Is Feasible for Chinese Breast Cancer Patients
por: He, Zhenyu, et al.
Publicado: (2014)

Seven fractions to deliver partial breast irradiation: the toxicity is Low
por: Trovo, Marco, et al.
Publicado: (2017)

Dose-volume histogram parameters and patient-reported EPIC-Bowel domain in prostate cancer proton therapy
por: Bulman, Gabriella F., et al.
Publicado: (2021)

Evaluation of Partial Breast Reirradiation with Intraoperative Radiotherapy after Prior Thoracic Radiation: A Single-Institution Report of Outcomes and Toxicity
por: Chin, Christine, et al.
Publicado: (2017)

Impact of Breast Size on Dosimetric Indices in Proton Versus X-ray Radiotherapy for Breast Cancer
por: Cunningham, Lisa, et al.
Publicado: (2021)

No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials
por: Haussmann, Jan, et al.
Publicado: (2020)

Biologically Effective Dose and Rectal Bleeding in Definitive Proton Therapy for Prostate Cancer
por: Bhangoo, Ronik S., et al.
Publicado: (2021)

Accelerated Atherosclerosis and Cardiovascular Toxicity Induced by Radiotherapy in Breast Cancer
por: Stefan, Miruna Florina, et al.
Publicado: (2023)

Early Experience Using Proton Beam Therapy for Extremity Soft Tissue Sarcoma: A Multicenter Study
por: Laughlin, Brady S., et al.
Publicado: (2022)

Comparison of adverse events in partial- or whole breast radiotherapy: investigation of cosmesis, toxicities and quality of life in a meta-analysis of randomized trials
por: Haussmann, Jan, et al.
Publicado: (2023)

Outcomes of Proton Beam Therapy Compared With Intensity-Modulated Radiation Therapy for Uterine Cancer
por: Anderson, Justin D., et al.
Publicado: (2022)

Hypofractionated versus conventional fractionated radiotherapy for breast cancer in patients with reconstructed breast: Toxicity analysis
por: Kim, Dong-Yun, et al.
Publicado: (2020)

Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy
por: Youssef, Fady F., et al.
Publicado: (2016)

Proton Partial Breast Irradiation: Detailed Description of Acute Clinico-Radiologic Effects
por: Ovalle, Valentina, et al.
Publicado: (2018)

Dosimetric Effect of Biozorb Markers for Accelerated Partial Breast Irradiation in Proton Therapy
por: Parham, Melton D., et al.
Publicado: (2021)

Toxicity and cosmesis outcomes after single fraction partial breast irradiation in early stage breast cancer
por: Pinnarò, Paola, et al.
Publicado: (2011)

Adjuvant radiotherapy after surgery in breast cancer: evaluation of acute toxicity
por: Molinaro, MA, et al.
Publicado: (2005)

Survival following gamma knife radiosurgery for brain metastasis from breast cancer
por: Jaboin, Jerry J, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8laccm66cucgolpem033mriqbd